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The purpose of this study was to introduce a new approach of micro-engineered membrane system 
which has a perfect hexagonal array of uniform pores to tailor size of biodegradable and 
bioresorbable drug-excipient based on the formation of polymeric nanoparticles (NPs) by solvent-
displacement (nanoprecipitation) method [1]. This system induced a rapid mixing process to control 
and limit the maximum level of supersaturation needed for nucleation due to defined mass transfer 
across the membrane, which allows for the generation of more nuclei and smaller size of NPs [2]. In 
this study, polycaprolactone (PCL) was chosen as a drug-carrier for nanoparticle fabrication due to its 
slow degradation, biocompatibility, having Food and Drug Administration (FDA) approval and 
commonly applied in pharmaceutical industry [3], while acetone (Ace) was used as a water-miscible 
volatile solvent (ICH, Class 2) [4]. Nanoparticles were produced instantaneously by fast diffusion once 
the organic phase is introduced through the membrane pores coming into contact with the aqueous 
phase that flows tangentially to the membrane surface. The organic phase containing 0.3 − 0.6 % 
(w/w) polymer in Ace was injected through the nickel micro-engineered membrane at different 
dependent experimental parameters; (i) organic phase injection rates (2 − 5 ml/min), (ii) agitation 
speeds (200 − 1300 rpm) and (iii) aqueous phase to organic phase volume ratios, Vaq/Vor (1.5, 3.0, 
4.5, 7.0, and 10.0).  The water phase containing 1 % (w/w) polyvinylalcohol (PVA) as a hydrophilic 
surfactant was filled in the stirred cell with 20 − 60 ml until a predetermined Vaq/Vor was achieved. The 
membranes containing uniform cylindrical pores we applied with a diameter of 10, 20 and 40 μm, 
arranged at a uniform spacing of 200 μm. The experimental set-up is depicted in Fig. 1. The 
nanoparticles were produced with a mean size of 205−276 nm depending upon the shear stress at 
the membrane surface caused by different values in stirring speeds. The physical characterisations of 
formulated nanoparticles were certainly proved by the X-ray diffractometry (XRD), differential 
scanning calorimetry (DSC) and Attenuated total reflection-Fourier transform infrared (ATR-FTIR).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Schematic diagram of the experimental setup used in this work 
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